Term
|
Definition
*relax muscle spasms
*prevent and treat malignant hyperthermia |
|
|
Term
|
Definition
|
|
Term
Expected Pharmacologic Action |
|
Definition
*inhibit release of calcium
*blocks muscle contraction |
|
|
Term
|
Definition
*muscle weakness
*drowsy, dizzy
*diarrhea
*liver toxicity (w/ higher doses and long term) |
|
|
Term
|
Definition
*monitor for: diarrhea, drowsiness, muscle strength, liver function tests
*start oral doses low and ↑ slow |
|
|
Term
|
Definition
*oral: given 1-2 days preop
*IV |
|
|
Term
|
Definition
*Report: weakness, prolonged diarrhea
*Avoid: driving, CNS depressants (ETOH)
*Potential liver damage |
|
|
Term
|
Definition
|
|
Term
|
Definition
* ♥ disease
* lung disease
*neuromuscular disorders
*pts older than 35yo |
|
|
Term
|
Definition
*estrogen ↑ risk of liver toxicity
*CNS depressants (ETOH) ↑ risk of severe sedations
*IV use: calcium channel blockers ↑ risk of severe dysrhythmias |
|
|